Table III.
Demographics characteristics and risk factors of first-time and repeat donors positive for markers of hepatitis C virus and human immunodeficiency virus in Italy, 2009–2015.
FT donors | RP donors | |||
---|---|---|---|---|
| ||||
HCV+ (n=1,658) N (%) |
HIV+ (n=291) N (%) |
HCV (n=238) N (%) |
HIV+ (n=454) N (%) |
|
Gender | ||||
Male | 1,106 (66.7) | 232 (79.7) | 150 (63) | 406 (89.4) |
| ||||
Female | 552 (33.3) | 59 (20.3) | 88 (37) | 48 (10.6) |
| ||||
Age group | ||||
18–25 | 122 (7.3) | 54 (18.6) | 15 (6.3) | 60 (13.2) |
| ||||
26–35 | 306 (18.5) | 99 (34.0) | 56 (23.6) | 157 (34.6) |
| ||||
36–45 | 564 (34.0) | 85 (29.2) | 75 (31.5) | 141 (31.1) |
| ||||
46–55 | 500 (30.2) | 44 (15.1) | 71 (29.8) | 76 (16.7) |
| ||||
56–65 | 163 (9.8) | 9 (3.1) | 20 (8.4) | 20 (4.4) |
| ||||
>65 | 3 (0.2) | - | 1 (0.4) | |
| ||||
Risk factor* | ||||
Sexual, of whom: | 171 (9.2) | 163 (49.2) | 41 (14.3) | 311 (60.6) |
| ||||
Heterosexual | 132 (77.2) | 104 (63.8) | 38 (92.7) | 193 (62.1) |
| ||||
MSM | 39 (22.8) | 59 (36.2) | 3 (7.3) | 118 (37.9) |
| ||||
Parenteral, of whom: | 425 (22.7) | 36 (10.9) | 89 (31.1) | 50 (9.7) |
| ||||
Intravenous drug use | 28 (6.6) | 1 (2.8) | 2 (2.2) | - |
| ||||
Dental treatment | 128 (30.1) | 8 (22.2) | 28 (31.5) | 14 (28.0) |
| ||||
Surgery | 124 (29.2) | 2 (5.6) | 25 (28.1) | 13 (26.0) |
| ||||
Transfusion | 37 (8.7) | 11 (30.5) | 2 (2.2) | - |
| ||||
Others (tattoo, piercing, etc.) | 108 (25.4) | 14 (38.9) | 32 (36.0) | 23 (46.0) |
| ||||
Household contact | 19 (1.0) | 1 (0.3) | 4 (1.4) | 4 (0.8) |
| ||||
Not identified** | 1,254 (67.1) | 131 (39.6) | 152 (53.2) | 148 (28.9) |
Each case could report more than one risk factor.
Not identified includes subjects (nearly 50%) who didn’t return to complete the post-donation interview.
FT: first-time; RP: repeat; HCV: hepatitis C virus; HIV: human immunodeficiency virus; MSM: males who have sex with males.